Multivariate decoding of brain images using ordinal regression

NeuroImage

Volumn 81, Issue , 2013, Pages 347-357

  Doyle, O M ^a   Ashburner, J ^b   Zelaya, F O ^a   Williams, S C R ^a   Mehta, M A ^a   Marquand, A F ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b WELLCOME TRUST CENTRE FOR NEUROIMAGING   (United Kingdom)

Author keywords

Gaussian processes; Ketamine; Multivariate; Ordinal regression; Pharmacological MRI; Scopolamine

Indexed keywords

DONEPEZIL; KETAMINE; LAMOTRIGINE; PLACEBO; RISPERIDONE; SCOPOLAMINE;

ACCURACY; ADULT; ANALYTICAL ERROR; ARTICLE; BRAIN BLOOD FLOW; BRAIN RADIOGRAPHY; CLASSIFICATION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ELECTROENCEPHALOGRAM; HUMAN; HUMAN EXPERIMENT; INTERMETHOD COMPARISON; MALE; MULTIVARIATE ANALYSIS; NEUROIMAGING; NEUROMODULATION; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; ORDINAL REGRESSION; PHARMACOLOGICAL NEUROIMAGING; PRIORITY JOURNAL; PROBABILITY; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; STATISTICAL MODEL; VOLUNTEER; ALGORITHM; BRAIN; BRAIN MAPPING; IMAGE PROCESSING; PHYSIOLOGY; PROCEDURES; YOUNG ADULT;

ADULT; ALGORITHMS; BRAIN; BRAIN MAPPING; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; REGRESSION ANALYSIS; YOUNG ADULT;

EID: 84878821133     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2013.05.036     Document Type: Article

References (58)

1. Akaike H. Stochastic theory of minimal realization. Vet. Med. Small Anim. Clin. 1974, Ac19:667-674.
2. Asai M., Fujikawa A., Noda A., Miyoshi S., Matsuoka N., Nishimura S. Donepezil- and scopolamine-induced rCMRglu changes assessed by PET in conscious rhesus monkeys. Ann. Nucl. Med. 2009, 23:877-882.
3. Ashburner J., Kloppel S. Multivariate models of inter-subject anatomical variability. NeuroImage 2011, 56:422-439.
4. Bartus R.T., Dean R.L., Beer B., Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982, 217:408-417.
5. Bishop C.M. Pattern Recognition and Machine Learning 2006, Springer, New York.
6. Borgwardt S., Koutsouleris N., Aston J., Studerus E., Smieskova R., Riecher-Rossler A., Meisenzahl E.M. Distinguishing prodromal from first-episode psychosis using neuroanatomical single-subject pattern recognition. Schizophr. Bull. 2013, (in press) (11 Sept 2013, Electronic publication ahead of print).
7. Chu W., Ghahramani Z. Gaussian processes for ordinal regression. J. Mach. Learn. Res. 2005, 6:1019-1041.
8. Chu C., Mourao-Miranda J., Chiu Y.C., Kriegeskorte N., Tan G., Ashburner J. Utilizing temporal information in fMRI decoding: classifier using kernel regression methods. NeuroImage 2011, 58:560-571.
9. Dai W.Y., Garcia D., de Bazelaire C., Alsop D.C. Continuous flow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields. Magn. Reson. Med. 2008, 60:1488-1497.
10. De Simoni S., Schwarz A.J., O'Daly O.G., Marquand A.F., Brittain C., Gonzales C., Stephenson S., Williams S.C., Mehta M.A. Test-retest reliability of the BOLD pharmacological MRI response to ketamine in healthy volunteers. NeuroImage 2013, 64:75-90.
11. Deakin J.F., Lees J., McKie S., Hallak J.E., Williams S.R., Dursun S.M. Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study. Arch. Gen. Psychiatry 2008, 65:154-164.
12. Di Santo S.G., Prinelli F., Adorni F., Caltagirone C., Musicco M. A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease. J. Alzheimer's Dis. 2013, 35:349-361.
13. Dietterich T.G., Bakiri G. Solving multiclass learning problems via error-correcting output codes. J. Artif. Int. Res. 1995, 2:263-286.
14. Doyle O.M., De Simoni S., Schwarz A.J., Brittain C., O'Daly O.G., Williams S.C.R., Mehta M.A. Quantifying the attenuation of the ketamine phMRI response in humans: a validation using antipsychotic and glutamatergic agents. J. Pharmacol. Exp. Ther. 2013, 345(1):151-160. (Apr).
15. Fan Y., ADNI Ordinal ranking for detecting mild cognitive impairment and Alzheimer's disease based on multimodal neuroimages and CSF biomarkers. Proceedings of the First International Conference on Multimodal Brain Image Analysis 2011, 44-51. Springer-Verlag, Toronto, Canada.
16. Fan Y., Shen D.G., Gur R.C., Gur R.E., Davatzikos C. COMPARE: classification of morphological patterns using adaptive regional elements. IEEE Trans. Med. Imaging 2007, 26:93-105.
17. Filippone M., Marquand A.F., Blain C.R.V., Williams S.C.R., Mourao-Miranda J., Girolami M. Probabilistic prediction of neurological disorders with a statistical assessment of neuroimaging data modalities. Ann. Appl. Stat. 2013, 6(4):1883-1905.
18. Friston K., Chu C., Mourao-Miranda J., Hulme O., Rees G., Penny W., Ashburner J. Bayesian decoding of brain images. NeuroImage 2008, 39:181-205.
19. Fusar-Poli P., Bechdolf A., Taylor M.J., Bonoldi I., Carpenter W.T., Yung A.R., McGuire P. At risk for schizophrenic or affective psychoses? A meta-analysis of DSM/ICD diagnostic outcomes in individuals at high clinical risk. Schizophr. Bull. 2013, (in press) (15 May 2013, Electronic publication ahead of print).
20. Gonen M., Alpaydin E. Multiple kernel learning algorithms. J. Mach. Learn. Res. 2011, 12:2211-2268.
21. Grasby P.M., Frith C.D., Paulesu E., Friston K.J., Frackowiak R.S., Dolan R.J. The effect of the muscarinic antagonist scopolamine on regional cerebral blood flow during the performance of a memory task. Exp. Brain Res. 1995, 104:337-348.
22. Gutiérrez P.A., Pérez-Ortiz M., Fernández-Navarro F., Sánchez-Monedero J., Hervás-Martínez C. An experimental study of different ordinal regression methods and measures. Hybrid Artificial Intelligent Systems 2012, 296-307. Springer, Berlin Heidelberg. E. Corchado, V. Snášel, A. Abraham, M. Woźniak, M. Graña, S.-B. Cho (Eds.).
23. Hassabis D., Chu C., Rees G., Weiskopf N., Molyneux P.D., Maguire E.A. Decoding neuronal ensembles in the human hippocampus. Curr. Biol. 2009, 19:546-554.
24. Honer W.G., Prohovnik I., Smith G., Lucas L.R. Scopolamine reduces frontal cortex perfusion. J. Cereb. Blood Flow Metab. 1988, 8:635-641.
25. Jack C.R., Bernstein M.A., Fox N.C., Thompson P., Alexander G., Harvey D., Borowski B., Britson P.J., Whitwell J.L., Ward C., Dale A.M., Felmlee J.P., Gunter J.L., Hill D.L.G., Killiany R., Schuff N., Fox-Bosetti S., Lin C., Studholme C., DeCarli C.S., Krueger G., Ward H.A., Metzger G.J., Scott K.T., Mallozzi R., Blezek D., Levy J., Debbins J.P., Fleisher A.S., Albert M., Green R., Bartzokis G., Glover G., Mugler J., Weiner M.W., Study A. The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods. J. Magn. Reson. Imaging 2008, 27:685-691.
26. Jenatton R., Gramfort A., Michel V., Obozinski G., Eger E., Bach F., Thirion B. Multiscale mining of fMRI data with hierarchical structured sparsity. SIAM J. Imag. Sci. 2012, 5:835-856.
27. Kendall M.G. A new measure of rank correlation. Biometrika 1938, 30:81-93.
28. Kriegeskorte N., Goebel R., Bandettini P. Information-based functional brain mapping. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:3863-3868.
29. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., Heninger G.R., Bowers M.B., Charney D.S. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch. Gen. Psychiatry 1994, 51:199-214.
30. Lenz R.A., Baker J.D., Locke C., Rueter L.E., Mohler E.G., Wesnes K., Abi-Saab W., Saltarelli M.D. The scopolamine model as a pharmacodynamic marker in early drug development. Psychopharmacology (Berl) 2012, 220:97-107.
31. Marquand A., Howard M., Brammer M., Chu C., Coen S., Mourao-Miranda J. Quantitative prediction of subjective pain intensity from whole-brain fMRI data using Gaussian processes. NeuroImage 2010, 49:2178-2189.
32. Marquand A.F., O'Daly O.G., De Simoni S., Alsop D.C., Maguire R.P., Williams S.C.R., Zelaya F.O., Mehta M.A. Dissociable effects of methylphenidate, atomoxetine and placebo on regional cerebral blood flow in healthy volunteers at rest: a multi-class pattern recognition approach. NeuroImage 2012, 60:1015-1024.
33. Mccullagh P. Regression-models for ordinal data. J. R. Stat. Soc. Ser. B Methodol. 1980, 42:109-142.
34. Mesulam M.M. Cholinergic pathways and the ascending reticular activating system of the human brain. Ann. N. Y. Acad. Sci. 1995, 757:169-179.
35. Mourao-Miranda J., Reynaud E., McGlone F., Calvert G., Brammer M. The impact of temporal compression and space selection on SVM analysis of single-subject and multi-subject fMRI data. NeuroImage 2006, 33:1055-1065.
36. Mourao-Miranda J., Reinders A.A.T.S., Rocha-Rego V., Lappin J., Rondina J., Morgan C., Morgan K.D., Fearon P., Jones P.B., Doody G.A., Murray R.M., Kapur S., Dazzan P. Individualized prediction of illness course at the first psychotic episode: a support vector machine MRI study. Psychol. Med. 2012, 42:1037-1047.
37. Mueller S.G., Weiner M.W., Thal L.J., Petersen R.C., Jack C.R., Jagust W., Trojanowski J.Q., Toga A.W., Beckett L. Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimers Dement. 2005, 1:55-66.
38. Ogawa M., Magata Y., Ouchi Y., Fukuyama H., Yamauchi H., Kimura J., Yonekura Y., Konishi J. Scopolamine abolishes cerebral blood flow response to somatosensory stimulation in anesthetized cats: PET study. Brain Res. 1994, 650:249-252.
39. Pantazatos S.P., Talati A., Pavlidis P., Hirsch J. Decoding unattended fearful faces with whole-brain correlations: an approach to identify condition-dependent large-scale functional connectivity. PLoS Comput. Biol. 2012, 8.
40. Pedregosa F., Cauvet E., Varoquaux G., Pallier C., Thirion B., Gramfort A. Improved brain pattern recovery through ranking approaches. Pattern Recognition in NeuroImaging (PRNI), 2012 International Workshop on 2012, 9-12.
41. Plant C., Teipel S.J., Oswald A., Bohm C., Meindl T., Mourao-Miranda J., Bokde A.W., Hampel H., Ewers M. Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimer's disease. NeuroImage 2010, 50:162-174.
42. Powell M.J.D. Efficient method for finding minimum of function of several-variables without calculating derivatives. Comput. J. 1964, 7:155-162.
43. Prohovnik I., Arnold S.E., Smith G., Lucas L.R. Physostigmine reversal of scopolamine-induced hypofrontality. J. Cereb. Blood Flow Metab. 1997, 17:220-228.
44. Rasmussen C.E., Nickisch H. Gaussian Processes for Machine Learning (GPML) toolbox. J. Mach. Learn. Res. 2010, 11:3011-3015.
45. Rasmussen C.E., Williams C.K.I. Gaussian Processes for Machine Learning 2006, MIT Press, Cambridge, Mass.
46. Schrouff J., Kusse C., Wehenkel L., Maquet P., Phillips C. Decoding semi-constrained brain activity from fMRI using support vector machines and Gaussian processes. PLoS One 2012, 7.
47. Schrouff J., Rosa M.J., Rondina J., Marquand A.F., Carlton C., Ashburner J., Phillips C., Richardi J., Mourao-Miranda J. PRoNTo: pattern recognition for neuroimaging toolbox. Neuroinformatics 2013, (in press) (Feb 16, Electronic publication ahead of print).
48. Schwarz G. Estimating dimension of a model. Ann. Stat. 1978, 6:461-464.
49. Smith S.M. Fast robust automated brain extraction. Hum. Brain Mapp. 2002, 17:143-155.
50. Snyder P.J., Bednar M.M., Cromer J.R., Maruff P. Reversal of scopolamine-induced deficits with a single dose of donepezil, an acetylcholinesterase inhibitor. Alzheimers Dement. 2005, 1:126-135.
51. Sperling R., Greve D., Dale A., Killiany R., Holmes J., Rosas H.D., Lake S., Lange N., Routledge C., Albert M. Functional MRI detection of pharmacologically induced memory impairment (vol 99, pg 455, 2002). Proc. Natl. Acad. Sci. U. S. A. 2002, 99:455-460.
52. Tauscher J., Jones C., Remington G., Zipursky R.B., Kapur S. Significant dissociation of brain and plasma kinetics with antipsychotics. Mol. Psychiatry 2002, 7:317-321.
53. Tota S., Hanif K., Kamat P.K., Najmi A.K., Nath C. Role of central angiotensin receptors in scopolamine-induced impairment in memory, cerebral blood flow, and cholinergic function. Psychopharmacology (Berl) 2012, 222:185-202.
54. Tsukada H., Kakiuchi T., Ando I., Ouchi Y. Functional activation of cerebral blood flow abolished by scopolamine is reversed by cognitive enhancers associated with cholinesterase inhibition: a positron emission tomography study in unanesthetized monkeys. J. Pharmacol. Exp. Ther. 1997, 281:1408-1414.
55. Williams C.K.I., Barber D. Bayesian classification with Gaussian processes. IEEE Trans. Pattern Anal. Mach. Intell. 1998, 20:1342-1351.
56. Winblad B., Engedal K., Soininen H., Verhey F., Waldemar G., Wimo A., Wetterholm A.L., Zhang R., Haglund A., Subbiah P., Grp D.N.S. A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. Neurology 2001, 57:489-495.
57. Yamamoto S., Nishiyama S., Kawamata M., Ohba H., Wakuda T., Takei N., Tsukada H., Domino E.F. Muscarinic receptor occupancy and cognitive impairment: a PET study with [C-11](+)3-MPB and scopolamine in conscious monkeys. Neuropsychopharmacology 2011, 36:1455-1465.
58. Zheng W., Ackley E.S., Martinez-Ramon M., Posse S. Spatially aggregated multiclass pattern classification in functional MRI using optimally selected functional brain areas. Magn. Reson. Imaging 2013, 31:247-261.